BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10430025)

  • 1. Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes?
    Nutt SL; Busslinger M
    Biol Chem; 1999 Jun; 380(6):601-11. PubMed ID: 10430025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent regulation of the two Pax5 alleles during B-cell development.
    Nutt SL; Vambrie S; Steinlein P; Kozmik Z; Rolink A; Weith A; Busslinger M
    Nat Genet; 1999 Apr; 21(4):390-5. PubMed ID: 10192389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis.
    Rhoades KL; Singh N; Simon I; Glidden B; Cedar H; Chess A
    Curr Biol; 2000 Jun; 10(13):789-92. PubMed ID: 10898982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential functions of Pax-5 (BSAP) in pro-B cell development.
    Nutt SL; Thévenin C; Busslinger M
    Immunobiology; 1997 Dec; 198(1-3):227-35. PubMed ID: 9442394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
    Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
    EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
    Heavey B; Charalambous C; Cobaleda C; Busslinger M
    EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of B cell commitment upon loss of Pax5 expression.
    Mikkola I; Heavey B; Horcher M; Busslinger M
    Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8.
    Dörfler P; Busslinger M
    EMBO J; 1996 Apr; 15(8):1971-82. PubMed ID: 8617244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
    Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
    Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
    Nutt SL; Heavey B; Rolink AG; Busslinger M
    Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in DNA binding activity of the transcription factor Pax-5a in B lymphocytes of aged mice.
    Anspach J; Poulsen G; Kaattari I; Pollock R; Zwollo P
    J Immunol; 2001 Feb; 166(4):2617-26. PubMed ID: 11160324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pax-5 gene is alternatively spliced during B-cell development.
    Zwollo P; Arrieta H; Ede K; Molinder K; Desiderio S; Pollock R
    J Biol Chem; 1997 Apr; 272(15):10160-8. PubMed ID: 9092562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
    Fuxa M; Busslinger M
    J Immunol; 2007 Jun; 178(12):8222-8. PubMed ID: 17600970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell commitment: Pax5 is the deciding factor.
    Enver T
    Curr Biol; 1999 Dec 16-30; 9(24):R933-5. PubMed ID: 10607584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
    Souabni A; Cobaleda C; Schebesta M; Busslinger M
    Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasticity of Pax-5(-/-) pre-B I cells.
    Bruno L; Schaniel C; Rolink A
    Cells Tissues Organs; 2002; 171(1):38-43. PubMed ID: 12021490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.
    Horcher M; Souabni A; Busslinger M
    Immunity; 2001 Jun; 14(6):779-90. PubMed ID: 11420047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pax-5 genes and CD19 molecules in human myeloma].
    Ishikawa H; Kawano M
    Rinsho Ketsueki; 2000 May; 41(5):404-7. PubMed ID: 10879100
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of Pax5 promotes plasma cell differentiation.
    Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
    Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
    Hart MR; Anderson DJ; Porter CC; Neff T; Levin M; Horwitz MS
    PLoS Genet; 2018 Sep; 14(9):e1007642. PubMed ID: 30216339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.